Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127202701 | 12720270 | 1 | I | 20160806 | 0 | 20160907 | 20160907 | DIR | US-FDA-349748 | FDA-CTU | 70.00 | YR | F | N | 83.25000 | KG | 20160903 | N | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127202701 | 12720270 | 1 | PS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | Oral | 20170620 | 0 | 28 | DF | COATED TABLET | QID | ||||||
| 127202701 | 12720270 | 3 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127202701 | 12720270 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 127202701 | 12720270 | 7 | C | UNIVASC | MOEXIPRIL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127202701 | 12720270 | 9 | C | CHLORTHALIDONE. | CHLORTHALIDONE | 1 | 0 | ||||||||||||
| 127202701 | 12720270 | 11 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 127202701 | 12720270 | 13 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 127202701 | 12720270 | 15 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 0 | ||||||||||||
| 127202701 | 12720270 | 17 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 127202701 | 12720270 | 19 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 127202701 | 12720270 | 21 | C | BUFFERED ASPIRIN | ASPIRIN | 1 | 0 | ||||||||||||
| 127202701 | 12720270 | 23 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 127202701 | 12720270 | 25 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 127202701 | 12720270 | 27 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127202701 | 12720270 | 1 | Infection |
| 127202701 | 12720270 | 1 | Jaw disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127202701 | 12720270 | OT |
| 127202701 | 12720270 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127202701 | 12720270 | Clostridium difficile infection | |
| 127202701 | 12720270 | Colitis | |
| 127202701 | 12720270 | Diarrhoea haemorrhagic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127202701 | 12720270 | 1 | 20160620 | 20160626 | 0 |